Patrick Malloy
Senior VP & Head of Investor RelationsMr. Patrick Malloy is Senior Vice President of Investor Relations & Strategic Communications of VectivBio Holding AG since April 2022. He serves as Senior Vice President of Investor Relations at ABIVAX Société Anonyme since August 23, 2023 and serves as its Head of Investor Relations. Mr. Malloy joins Abivax from VectivBio AG (acquired by Ironwood Pharmaceuticals in June 2023), where he held the position of Senior Vice President, Investor Relations & Strategic Communications. He was Vice President of Investor Relations & Corporate Communications of Arena Pharmaceuticals, Inc. Prior joining Arena, He spent at Actelion Pharmaceuticals (acquired by Johnson and Johnson in June 2017) where he held several commercial and corporate strategic leadership roles across the organization.
Positions
- Company NameABIVAX Société AnonymeStock CodeABVXPositionSenior VP & Head of Investor RelationsColleagues
- MMMarc M. P. de GaridelCEO & Director
- SLSylvie L. GregoireIndependent Chair of the Board
- DBDidier BlondelEVP, CFO & Board Secretary
- TPTimothy P. KellyChief Technical Officer
- IHIda HatoumChief People & Compliance Officer
- IMIan McGowanChairman of Scientific Advisory Board
- JHJune H. LeeIndependent Director
- TATroy A. IgnelziIndependent Director
